Active	Status	Sponsor type	Region	Phase	Filter
26 Active 16 Inactive 42 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Liu, Yan
NCT06350890: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes	Active, not recruiting	3	408	RoW	HTD1801, berberine ursodeoxycholate, Placebo	HighTide Biopharma Pty Ltd	T2DM (Type 2 Diabetes Mellitus)	03/25	09/25
Symphony2, NCT06353347: Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin	Active, not recruiting	3	551	RoW	HTD1801, berberine ursodeoxycholate, Placebo	HighTide Biopharma Pty Ltd	Type 2 Diabetes Mellitus	03/25	12/25
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis	Recruiting	3	552	RoW	ICP-332 Tablets, ICP-332 Placebo Tablets	Beijing InnoCare Pharma Tech Co., Ltd.	Atopic Dermatitis	11/26	12/26